Covered recipient · General Payments record
MICHAEL GILMORE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$1,338.67
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $157.30 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $50.38 | 2 |
| Avanir Pharmaceuticals, Inc. | $35.81 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.15 | 1 |
| Apria Healthcare LLC | $15.33 | 1 |
| Amgen Inc. | $12.69 | 1 |
| Biohaven Pharmaceuticals, Inc. | $12.59 | 1 |
| Janssen Pharmaceuticals, Inc | $11.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $28.24 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794598397 | CMS |
| AbbVie Inc. | $22.14 | 08/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794598401 | CMS |
| Amgen Inc. | $12.69 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825618401 | CMS |
| Apria Healthcare LLC | $15.33 | 07/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 835104689 | CMS |
| Avanir Pharmaceuticals, Inc. | $17.56 | 01/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801044305 | CMS |
| Avanir Pharmaceuticals, Inc. | $18.25 | 03/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801037751 | CMS |
| Biohaven Pharmaceuticals, Inc. | $12.59 | 03/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852499165 | CMS |
| Janssen Pharmaceuticals, Inc | $11.35 | 02/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788699395 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.15 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 850245029 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.